Tracy S. Anderson has established an impressive career in the medical market by integrating his expertise as a skilled surgical technician with his corporate experience. A graduate of the University of Georgia, Mr. Anderson began working in the medical industry as a Cardiopulmonary Systems Specialist with Baxter Healthcare. After Baxter, he helped develop two intraocular lens companies, Ioptex, Inc. and Chiron, from the ground up.

In 2002, Mr. Anderson founded Atlanta-based T2MED, Inc., one of the Southeast’s most innovative private companies in the growing spinal device market. In 2008, he merged T2 into Amendia, Inc. as one of its founding partners. With Mr. Anderson as the President of its Sales and Marketing group, Amendia grew to over $85 million in sales before being acquired by private equity for $190 million. In December 2012, Mr. Anderson licensed a unique stem cell lineage from the University of Miami for potential use in general orthopedics. In March of 2013, VIVEX Biologics was spun out from Amendia as a freestanding entity.

In November 2014, Mr. Anderson was instrumental in the acquisition of the University of Miami Tissue Bank, the oldest and one of the most prestigious human tissue facilities in the world. UMTB immediately became VIVEX Biologics, a fully owned subsidiary of VIVEX Biologics, Inc. In July of 2019, Mr. Anderson transitioned from his role as President and CEO to the role of Vice Chairman. He remains a member of the Board of Directors. Through his leadership and innovation, VIVEX Biologics has grown to become a leading tissue and cell therapy company with scientifically based technologies, an unsurpassed patent portfolio, and significant revenue in the spine and orthopedic space.

Throughout his career, Mr. Anderson has partnered with some of the medical industry’s top experts in the areas of general orthopedics, spine surgery, sports medicine, cardiovascular surgery, ophthalmic surgery, and oncology. He is a member of several other professional organizations and advisory boards, including the Advisory Committee for Surgical Technology at Gwinnett Tech in Lawrenceville, Georgia.